XClose

UCL Cancer Institute

Home
Menu

Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme are open, with new Samuel Fund Scholarships available for 2016/17 entry. 

News


New team to develop radiotherapies that target cancer more effectively

Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust. UCL and UCLH have appointed Professor Ricky Sharma, a world-leading oncologist from Oxford University specialising in radiotherapy and cancer biology, to lead the new clinical research programme alongside a team of top physicists.

Published: Apr 21, 2016 10:37:41 PM

Gene editing activates cancer-killing immune cells

In a new study published today in Cancer Research, a UCL research team led by Professor Karl Peggs and Dr Sergio Quezada have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer. 

Published: Apr 15, 2016 1:22:05 PM

New genetics discovery paves the way to transform immunotherapy treatments

An international team of scientists, led by Dr Sergio Quezada and Professor Charles Swanton, have made a groundbreaking discovery in understanding how the genetic complexity of cancerous tumours can be recognised and exploited by the immune system, even when the disease is at its most advanced stages. 

Published: Mar 11, 2016 3:58:24 PM

Cancer drug could treat blood vessel deformities

A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.

Published: Mar 11, 2016 3:58:24 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute us uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.

Events

Key Advances in Clinical Trials

To mark International Clinical Trials Day, UCL Institute of Clinical Trials and Methodology will be holding a special event to showcase some of the ground-breaking trials conducted by the four UCL clinical trials units. 

Starts: May 20, 2016 9:30:00 AM

Science at Hay Festival 2016

Sergio Quezada, Rebecca Kristeleit and Tim Elliot will be at Hay Festival to present Could the Body's Natural Defence Systems Hold the Key to Beating Cancer? Saturday 28 May 2016, 7.00pm. 

Starts: May 28, 2016 7:00:00 PM

Support our work

The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer. 

Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.

Donate

Taking action for equality

Athena Swan silver logo

Connect with us

TwitterYoutubeMail